AR041639A1 - Metodo para la sintesis de un compuesto de bencimidazol - Google Patents
Metodo para la sintesis de un compuesto de bencimidazolInfo
- Publication number
- AR041639A1 AR041639A1 ARP030103769A ARP030103769A AR041639A1 AR 041639 A1 AR041639 A1 AR 041639A1 AR P030103769 A ARP030103769 A AR P030103769A AR P030103769 A ARP030103769 A AR P030103769A AR 041639 A1 AR041639 A1 AR 041639A1
- Authority
- AR
- Argentina
- Prior art keywords
- methoxy
- pyridinyl
- dimethyl
- formula
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
Abstract
Reivindicación 1: Un proceso para la fabricación de 5-metoxi-2-[[(4-metoxi-3,5-dimetil-2-piridinil)metil]tio-1H-bencimidazol de la fórmula (1), a partir de alcohol (4-metoxi-3,5-dimetil-2-piridinil)-metílico que comprende las siguientes etapas de reacción llevadas a cabo en un orden consecutivo en un único sistema de solvente principal sin aislamiento de los intermediarios formados durante el proceso, Etapa 1: reacción de alcohol (4-metoxi-3,5-dimetil-2-piridinil)-metílico (alcohol pirmetílico) de la fórmula (2), con un agente cloro-deshidroxilante, proporcionado cloruro de (4-metoxi-3,5-dimetil-2-piridinil)-metilo (cloruro de pirmetilo) de la fórmula (3); Etapa 2: reacción del cloruro de (4-metoxi-3,5-dimetil-2-piridinil)-metilo de la fórmula (3), preparado en la etapa 1, con 2-mercapto-5-metoxi-bencimidazol (metmercazol) de la fórmula (4), en presencia de una base, proporcionando el 5-metoxi-2-[[(4-metoxi-3,5-dimetil-2-piridinil)metil]-tio]-1H-bencimidazol (pirmetazol) de la fórmula (1), caracterizado porque el sistema de solvente, común para toda la secuencia de reacción, comprende el sistema de solvente, común para toda la secuencia de reacción, comprende solvente orgánico no miscible con agua con una cantidad adicionada específica en el orden entre 0,3 y 5,5 mg de agua/ml de solvente orgánico no miscible con agua.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0203092A SE0203092D0 (en) | 2002-10-18 | 2002-10-18 | Method for the synthesis of a benzimidazole compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR041639A1 true AR041639A1 (es) | 2005-05-26 |
Family
ID=20289310
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP030103769A AR041639A1 (es) | 2002-10-18 | 2003-10-16 | Metodo para la sintesis de un compuesto de bencimidazol |
Country Status (32)
| Country | Link |
|---|---|
| US (2) | US7227024B2 (es) |
| EP (1) | EP1556370B1 (es) |
| JP (1) | JP4551221B2 (es) |
| KR (1) | KR101065885B1 (es) |
| CN (2) | CN101230057B (es) |
| AR (1) | AR041639A1 (es) |
| AT (1) | ATE398118T1 (es) |
| AU (1) | AU2003269773B2 (es) |
| BR (1) | BR0315254A (es) |
| CA (1) | CA2501542C (es) |
| CY (1) | CY1108255T1 (es) |
| DE (1) | DE60321588D1 (es) |
| DK (1) | DK1556370T3 (es) |
| ES (1) | ES2306883T3 (es) |
| HK (1) | HK1078852A1 (es) |
| IL (1) | IL167795A (es) |
| IS (1) | IS2590B (es) |
| MX (1) | MXPA05003994A (es) |
| MY (1) | MY133573A (es) |
| NO (1) | NO330785B1 (es) |
| NZ (1) | NZ539370A (es) |
| PL (1) | PL376819A1 (es) |
| PT (1) | PT1556370E (es) |
| RU (1) | RU2324691C2 (es) |
| SA (1) | SA03240344B1 (es) |
| SE (1) | SE0203092D0 (es) |
| SI (1) | SI1556370T1 (es) |
| TW (1) | TWI310382B (es) |
| UA (1) | UA79147C2 (es) |
| UY (1) | UY28025A1 (es) |
| WO (1) | WO2004035565A1 (es) |
| ZA (1) | ZA200502577B (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0203092D0 (en) * | 2002-10-18 | 2002-10-18 | Astrazeneca Ab | Method for the synthesis of a benzimidazole compound |
| ZA200706613B (en) * | 2004-12-16 | 2009-03-25 | Cipla Ltd | Process |
| WO2010134099A1 (en) | 2009-05-21 | 2010-11-25 | Cadila Healthcare Limited | One pot process for preparing omeprazole and related compounds |
| US8895271B2 (en) | 2009-12-08 | 2014-11-25 | Codexis, Inc. | Synthesis of prazole compounds |
| HUE037616T2 (hu) | 2010-12-08 | 2018-09-28 | Codexis Inc | Biokatalizátorok és eljárások armodafinil szintéziséhez |
| CN103570681A (zh) * | 2012-07-24 | 2014-02-12 | 江苏柯菲平医药有限公司 | 一种埃索美拉唑关键中间体的制备方法 |
| CN103232389A (zh) * | 2013-05-08 | 2013-08-07 | 浙江新三和医药化工股份有限公司 | 2-氯甲基-4-甲氧基-3,5-二甲基吡啶盐酸盐的制备方法 |
| CN103524494A (zh) * | 2013-11-07 | 2014-01-22 | 安徽国星生物化学有限公司 | 含甲基吡啶基团的巯基咪唑类衍生物及合成方法 |
| CN108251466B (zh) * | 2016-12-28 | 2021-07-02 | 浙江京新药业股份有限公司 | 一种酶法合成埃索美拉唑的方法 |
| CN107400118B (zh) * | 2017-08-29 | 2020-07-28 | 信泰制药（苏州）有限公司 | 埃索美拉唑中间体的制备方法 |
| CN111943883A (zh) * | 2020-08-21 | 2020-11-17 | 抚州三和医药化工有限公司 | 一种奥美氯化物的生产工艺 |
| KR20220084718A (ko) | 2020-12-14 | 2022-06-21 | 메디케어제약 주식회사 | 기능성 소화 불량을 동반한 위식도 역류 질환을 치료하는 약제학적 복합제제 |
| KR20230090184A (ko) | 2021-12-14 | 2023-06-21 | 메디케어제약 주식회사 | 에스오메프라졸 및 레바미피드를 포함하는 약제학적 복합제제 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7804231L (sv) * | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
| US4619997A (en) * | 1984-09-06 | 1986-10-28 | The Upjohn Company | Substituted 2-pyridylmethylthio and sulfinyl-benzimidazoles as gastric antisecretory agents |
| SE9002043D0 (sv) | 1990-06-07 | 1990-06-07 | Astra Ab | Improved method for synthesis |
| NZ244301A (en) * | 1991-09-20 | 1994-08-26 | Merck & Co Inc | Preparation of 2-pyridylmethylsulphinylbenzimidazole and pyridoimidazole derivatives from the corresponding sulphenyl compounds |
| KR100236853B1 (ko) * | 1995-07-03 | 2000-02-01 | 야마모토 카즈모토 | 1-(5-이소퀴놀린술포닐)호모피페라진 염산염 수화물 |
| SE521100C2 (sv) * | 1995-12-15 | 2003-09-30 | Astra Ab | Förfarande för framställning av en bensimidazolförening |
| SE9704183D0 (sv) * | 1997-11-14 | 1997-11-14 | Astra Ab | New process |
| SI20019A (sl) * | 1998-07-13 | 2000-02-29 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Izboljšan postopek sinteze 5-metoksi -2-/(4-metoksi-3,5-dimetil-2-piridil)metil/ sulfinil-1H-benzimidazola |
| SE0203092D0 (en) * | 2002-10-18 | 2002-10-18 | Astrazeneca Ab | Method for the synthesis of a benzimidazole compound |
-
2002
- 2002-10-18 SE SE0203092A patent/SE0203092D0/xx unknown
-
2003
- 2003-10-09 TW TW092128112A patent/TWI310382B/zh not_active IP Right Cessation
- 2003-10-14 SA SA03240344A patent/SA03240344B1/ar unknown
- 2003-10-15 ES ES03751703T patent/ES2306883T3/es not_active Expired - Lifetime
- 2003-10-15 CN CN2008100040145A patent/CN101230057B/zh not_active Expired - Lifetime
- 2003-10-15 WO PCT/SE2003/001602 patent/WO2004035565A1/en active IP Right Grant
- 2003-10-15 MX MXPA05003994A patent/MXPA05003994A/es active IP Right Grant
- 2003-10-15 AU AU2003269773A patent/AU2003269773B2/en not_active Expired
- 2003-10-15 JP JP2004545137A patent/JP4551221B2/ja not_active Expired - Fee Related
- 2003-10-15 UA UAA200502927A patent/UA79147C2/uk unknown
- 2003-10-15 PL PL376819A patent/PL376819A1/pl unknown
- 2003-10-15 EP EP03751703A patent/EP1556370B1/en not_active Expired - Lifetime
- 2003-10-15 BR BR0315254-5A patent/BR0315254A/pt not_active IP Right Cessation
- 2003-10-15 CN CNB2003801014302A patent/CN100374436C/zh not_active Expired - Lifetime
- 2003-10-15 US US10/531,412 patent/US7227024B2/en not_active Expired - Lifetime
- 2003-10-15 PT PT03751703T patent/PT1556370E/pt unknown
- 2003-10-15 DE DE60321588T patent/DE60321588D1/de not_active Expired - Lifetime
- 2003-10-15 NZ NZ539370A patent/NZ539370A/en not_active IP Right Cessation
- 2003-10-15 RU RU2005109270/04A patent/RU2324691C2/ru active
- 2003-10-15 CA CA2501542A patent/CA2501542C/en not_active Expired - Fee Related
- 2003-10-15 KR KR1020057006554A patent/KR101065885B1/ko not_active IP Right Cessation
- 2003-10-15 SI SI200331301T patent/SI1556370T1/sl unknown
- 2003-10-15 DK DK03751703T patent/DK1556370T3/da active
- 2003-10-15 AT AT03751703T patent/ATE398118T1/de active
- 2003-10-16 UY UY28025A patent/UY28025A1/es not_active Application Discontinuation
- 2003-10-16 MY MYPI20033949A patent/MY133573A/en unknown
- 2003-10-16 AR ARP030103769A patent/AR041639A1/es not_active Application Discontinuation
-
2005
- 2005-03-30 ZA ZA200502577A patent/ZA200502577B/en unknown
- 2005-03-31 IL IL167795A patent/IL167795A/en not_active IP Right Cessation
- 2005-05-02 NO NO20052158A patent/NO330785B1/no not_active IP Right Cessation
- 2005-05-03 IS IS7834A patent/IS2590B/is unknown
- 2005-11-24 HK HK05110641.7A patent/HK1078852A1/xx not_active IP Right Cessation
-
2007
- 2007-05-16 US US11/749,282 patent/US7683178B2/en active Active
-
2008
- 2008-08-12 CY CY20081100852T patent/CY1108255T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR041639A1 (es) | Metodo para la sintesis de un compuesto de bencimidazol | |
| PE20030976A1 (es) | Piridinoilpiperidinas como agonistas de 5-ht1f | |
| AR010634A1 (es) | Composicion farmaceutica en forma de una solucion para la administracion de inhibidores de proteasa hiv | |
| DE60030741D1 (de) | Chinazoline verbindungen als heilmittel | |
| EA200600206A1 (ru) | Таблетки с модифицированным высвобождением гидрохлорида бупропиона | |
| PE20020707A1 (es) | Compuestos tripeptidicos como inhibidores de la proteasa ns3 del virus de hepatitis c | |
| AR022461A1 (es) | Compuesto de 5-hidroxiindol sustituido; proceso para su preparacion y composicion farmaceutica que lo contiene | |
| CO5570660A2 (es) | Indazolilpirrolotriazinas c-6 modificadas | |
| DE69503604D1 (de) | Stabilisierte orthokieselsäure enthaltende zubereitung sowie biologische zubereitung | |
| AR004834A1 (es) | Procedimiento de la manufactura de (5-metoxi-2[[(4-metoxi-3,5-dimetil-2- piridinil)-metil]-sulfinil]-1h-bencimidazol (omeprazol) | |
| AR079399A2 (es) | Procedimientos para preparar bifenazato | |
| EA200500898A1 (ru) | Способ получения оптически чистых активных соединений | |
| RU98110659A (ru) | Способ синтеза соединений бензимидазола | |
| ATE466008T1 (de) | P-glycoprotein-inhibitor, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die diesen enthält | |
| GT199800196A (es) | Combinaciones de estatina-eter carboxialquilico. | |
| AR027335A1 (es) | Compuestos de piperidina-4-sulfonamida, proceso de preparacion de los mismos, y composiciones farmaceuticas que los contienen | |
| AR046065A1 (es) | Cristales de penam y procedimiento para la produccion de los mismos | |
| JP2006505567A5 (es) | ||
| EP1420028A3 (fr) | Pocédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables | |
| ECSP003680A (es) | Proceso para derivados del acido fenilacetico | |
| HK1064602A1 (en) | S-omeprazole (esomeprazole) inclusion complex withcyclodextrins. | |
| AR051386A1 (es) | Proceso para compuestos triciclicos que contienen atomos heterogeneos | |
| NO20044466L (no) | Plasma-karboksypeptidase B-inhibitorer | |
| ES2178382T3 (es) | Compuestos de benciloxiprodigiosina. | |
| UY28651A1 (es) | Metodos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |